Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy

American Journal of Roentgenology

Volumn 189, Issue 2, 2007, Pages 468-474

  Lee, Jung Min ^a   Kaplan, Jennifer B ^a   Murray, Melissa P ^a   Mazur Grbec, Marzena ^a,b   Tadic, Tade ^a,c   Stimac, Damir ^a,d   Liberman, Laura ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KBC RIJEKA   (Croatia)

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

^d UNIVERSITY HOSPITAL OSIJEK   (Croatia)

Author keywords

Biopsy; Breast cancer; Breast imaging; Ductal carcinoma in situ; MRI

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; DIAGNOSTIC ERROR; FEMALE; HISTOPATHOLOGY; HUMAN; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VACUUM;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHI-SQUARE DISTRIBUTION; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MIDDLE AGED; RETROSPECTIVE STUDIES; VACUUM;

EID: 34547572051     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2172     Document Type: Article

References (23)

1. Liberman L. Clinical management issues in percutaneous core breast biopsy. In: Feig SA, ed. The radiologic clinics of North America: breast imaging. Philadelphia, PA: Saunders, 2000:791-807
2. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218:497-502
3. Liberman L, Kaplan JB, Morris EA, Abramson AF, Menell JH, Dershaw DD. To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? AJR 2002; 179:679-683
4. Liberman L, Goodstine SL, Dershaw DD, et al. One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factors. AJR 2002; 178:673-679
5. Liberman L, Morris EA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR 2003;181:1283-1293
6. Lehman CD, DePeri ER, Peacock S, McDonough MD, DeMartini WB, Shook JS. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR 2005; 184:1782-1787
7. Liberman L, Bracero N, Morris EA, Thornton C, Dershaw DD. MRI-guided 9-gauge vacuum-assisted biopsy: initial clinical experience. AJR 2005; 185:183-193
8. Orel SG, Rosen M, Miles C, Schnall MD. MR imaging-guided 9-gauge vacuum-assisted core needle breast biopsy: initial experience. Radiology 2006; 238:54-61
9. Tavasoli FA, Devilee P. World Health Organization classification of tumors: tumors of the breast and female genital organs. Lyon, France: IARC Press, 2003
10. Silver S, Tavassoli FA. Ductal carcinoma in situ with microinvasion. Breast J 1998; 4:344-348
11. Padmore RF, Fowble B, Hoffman J. Microinvasive breast carcinoma: clinicopathologic analysis 88:1403-1409
12. American College of Radiology (ACR). Magnetic resonance imaging. In: ACR Breast Imaging Reporting and Data System, breast imaging atlas. Reston, VA: American College of Radiology, 2003
13. Lentner C. 'Exact' confidence limits for p. In: Lentner C, ed. Geigy scientific tables, vol. 2. Introduction to statistics, statistical tables, mathematical formulae. Basle, Switzerland: CibaGeigy, 1982:89-102
14. Lee CH, Carter D, Philpotts LE, et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 2000; 217:466-470
15. Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 2002; 224:548-554
16. Liberman L, Holland AE, Marjan D, et al. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR 2007; 188:684-690
17. Rosenblatt R, Fineberg SA, Sparano JA, Kaleya RN. Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient care. Radiology 1996; 201:67-70
18. Klauber-Demore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000; 7:636-642
19. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR 2003; 181:619-626
20. Liberman L, Morris EA, Lee MJY, et al. Breast lesions detected by MR imaging: features and positive predictive value. AJR 2002; 179:171-178
21. Bartella L, Liberman L, Morris EA, Dershaw DD. Nonpalpable mammographically occult invasive breast cancers detected by MRI. AJR 2006; 186:865-870
22. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211:101-110
23. Arkani S, Abe H, Schmidt R, Karczmar G, Newstead G. MR imaging of pure ductal carcinoma in situ: kinetics, morphology, and correlation with mammographic presentation and nuclear grade, (abstr) Radiological Society of North America scientific assembly and annual meeting program. Oak Brook, IL: RSNA, 2006:519